The founder of the Multidisciplinary Association for Psychedelic Studies (MAPS) believes research on MDMA, known commonly as the club drug ecstasy, could lead other hallucinogenic drugs to gain medical acceptance.

“I think MDMA is going to be the psychedelic that leads the way towards opening the door to other psychedelics, because they’re more challenging,” Rick Doblin said in an interview. “And so just the way that MDMA can help the individual deal with a past trauma, MDMA can help our society deal with the trauma of the sixties” when the drugs were abused and outlawed. Via Raw Story.